We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$365B
AUM Growth
+$31.5B
Cap. Flow
+$13.3B
Cap. Flow %
3.65%
Top 10 Hldgs %
14.17%
Holding
6,934
New
268
Increased
3,628
Reduced
2,353
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 10.97%
2 Financials 10.16%
3 Consumer Discretionary 8.05%
4 Healthcare 7.74%
5 Communication Services 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HFBC
6001
DELISTED
HopFed Bancorp Inc
HFBC
$13K ﹤0.01%
950
JJS
6002
DELISTED
iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038
JJS
$13K ﹤0.01%
392
-14
-3% -$431
WAC
6003
DELISTED
Walter Investment Mgt Corp
WAC
$13K ﹤0.01%
14,841
+2,810
+23% +$1.51K
GCVRZ
6004
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$13K ﹤0.01%
33,863
+478
+1% +$181
ADMA icon
6005
ADMA Biologics
ADMA
$2.22B
$12K ﹤0.01%
3,774
-1,089
-22% -$3.05K
CVV icon
6006
CVD Equipment Corp
CVV
$56.8M
$12K ﹤0.01%
1,003
-4,826
-83% -$55.5K
EVOK
6007
DELISTED
Evoke Pharma
EVOK
$12K ﹤0.01%
37
-4
-10% -$1.66K
LARK icon
6008
Landmark Bancorp
LARK
$195M
$12K ﹤0.01%
595
+1
+0.2% +$19
SDG icon
6009
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
$12K ﹤0.01%
200
VCEL icon
6010
Vericel Corp
VCEL
$2.31B
$12K ﹤0.01%
2,265
-6,740
-75% -$31.1K
WEAT icon
6011
Teucrium Wheat Fund
WEAT
$295M
$12K ﹤0.01%
+400
New +$12.4K
GPUS
6012
Hyperscale Data Inc
GPUS
$55.4M
0
ALPN
6013
DELISTED
Alpine Immune Sciences Inc
ALPN
$12K ﹤0.01%
1,037
-1,500
-59% -$16.3K
GGE
6014
DELISTED
Green Giant Inc. Common Stock
GGE
$12K ﹤0.01%
+4,702
New +$12.6K
MIME
6015
DELISTED
Mimecast Limited
MIME
$12K ﹤0.01%
430
-60,415
-99% -$1.8M
GGO
6016
DELISTED
The Gabelli Go Anywhere Trust
GGO
$12K ﹤0.01%
708
SAUC
6017
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$12K ﹤0.01%
7,984
+1,247
+19% +$2.02K
ATXS
6018
DELISTED
Astria Therapeutics
ATXS
$11K ﹤0.01%
117
+30
+34% +$3.53K
CPSH icon
6019
CPS Technologies
CPSH
$86.1M
$11K ﹤0.01%
6,341
+1,001
+19% +$1.3K
EMDV icon
6020
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.39M
$11K ﹤0.01%
180
+30
+20% +$1.66K
FENG
6021
Phoenix New Media
FENG
$18M
$11K ﹤0.01%
271
-637
-70% -$23.7K
TMQ
6022
Trilogy Metals
TMQ
$656M
$11K ﹤0.01%
10,631
-649
-6% -$623
ZSL icon
6023
ProShares UltraShort Silver
ZSL
$52.3M
$11K ﹤0.01%
2
-7
-78% -$36.3K
FGH
6024
DELISTED
FG Group Holdings Inc.
FGH
$11K ﹤0.01%
2,356
+300
+15% +$1.61K
GNMX
6025
DELISTED
Aevi Genomic Medicine Inc
GNMX
$11K ﹤0.01%
8,712
+1,669
+24% +$2.28K

Similar funds

Morgan Stanley's Q4 2017 Portfolio in Review

As of Q4 2017, Morgan Stanley held 6,934 positions worth $365B, up 9.4% from $334B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $13.3B of net new capital in Q4 2017, opening 268 new positions and adding to 3,628 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $1.45B trimmed.

  • Morgan Stanley's largest Q4 2017 buy was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $4.24B increase.
  • Morgan Stanley's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.45B.
  • Morgan Stanley fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $210M.
  • Morgan Stanley's ten largest holdings make up 14% of its $365B portfolio in Q4 2017.
  • Morgan Stanley opened 268 new positions and closed 177 in Q4 2017.
  • Morgan Stanley's portfolio value rose 9.4% quarter-over-quarter to $365B.

Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.